| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | +7.51% | -1.75% | +9.26% | +10.26% | — |
| 14d | 6 | +100.00% | +10.53% | -2.03% | +15.36% | +14.87% | — |
| 30d | 6 | +100.00% | +8.54% | -1.61% | +10.15% | +12.75% | — |
| 60d | 6(1 pending) | +80.00% | +11.89% | -5.87% | +17.77% | +19.29% | — |
| 90d | 6(1 pending) | +60.00% | +26.68% | -0.48% | +27.16% | +58.04% | — |
| 180d | 6(1 pending) | +60.00% | +29.66% | +2.20% | +27.45% | +80.43% | — |
| 1y | 6(1 pending) | +100.00% | +237.44% | +16.42% | +221.02% | +349.87% | — |
| 2y | 6(6 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RAPP RAPPORT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 18,572 | $40.05 | $743.8K | 6,280,525 | May 26, 2026 | May 28, 2026 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 133,618 | $40.24 | $5.38M | 6,299,097 | May 11, 2026 | May 13, 2026 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,018 | $40.31 | $202.3K | 6,432,715 | May 8, 2026 | May 11, 2026 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 271,495 | $40.12 | $10.89M | 6,437,733 | May 7, 2026 | May 11, 2026 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 426,005 | $40.32 | $17.18M | 6,709,228 | Apr 17, 2026 | Apr 21, 2026 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 1,600,000 | — | — | 4,473,958 | Nov 4, 2025 | Nov 5, 2025 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 18,861 | $6.00 | $113.1K | 4,211,659 | Feb 24, 2025 | Feb 26, 2025 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 427,668 | $5.94 | $2.54M | 4,192,798 | Feb 21, 2025 | Feb 24, 2025 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 612,674 | $5.92 | $3.63M | 3,765,130 | Feb 20, 2025 | Feb 24, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASE | 950,800 | — | — | 950,800 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 45,833,334 | — | — | 0 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 9,725,709 | — | — | 0 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | SALE | 9,166,666 | — | — | 0 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| MAZE MAZE THERAPEUTICS, INC. | PURCHASE | 5,762,788 | — | — | 6,073,958 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 4,790,773 | — | — | 5,845,091 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE | 24,737,017 | — | — | 0 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| SEPN SEPTERNA, INC. | SALE | 41,250,000 | — | — | 0 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 370,500 | $18.00 | $6.67M | 6,215,591 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 279,500 | $18.00 | $5.03M | 3,152,456 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| SEPN SEPTERNA, INC. | PURCHASE | 2,872,956 | — | — | 2,872,956 | Oct 28, 2024 | Oct 28, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | PURCHASE | 6,551,449 | — | — | 7,135,233 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 298,103 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 8,000,000 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 56,091,177 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | PURCHASE | 969,218 | — | — | 969,218 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |